Patents Assigned to FTGEN Corp
  • Patent number: 12781244
    Abstract: The present invention relates to a system for treating eye diseases, and a method for treating eye diseases using the system.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: November 3, 2026
    Assignee: FTGEN Corp
    Inventors: Zhongdong Shi, Wei Zhao
  • Patent number: 12734251
    Abstract: Provided herein are compositions for treating or preventing Retinitis Pigmentosa. The compositions comprise a first polynucleotide and a second polynucleotide. The compositions may further comprise a third sequence and a fourth sequence. Also provided herein are the recombinant adeno-associated virus particles, systems, methods, and kits for practicing or using the same.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: September 15, 2026
    Assignee: FTGEN Corp
    Inventors: Zhongdong Shi, Wei Zhao